Liver Cancer
Copyright ©2005 Baishideng Publishing Group Inc.
World J Gastroenterol. Oct 28, 2005; 11(40): 6258-6261
Published online Oct 28, 2005. doi: 10.3748/wjg.v11.i40.6258
Figure 1
Figure 1 TRAIL-induced NFκB activation in HLE cells (A,B).
Figure 2
Figure 2 Proliferation of HLE (A), HepG2 (B), SK-Hep1 (C) cells induced by TNFα (1), Fas ligand (2), TRAIL (3), doxorubicin (4), and camptotecin (5).